Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 7/20 | 0.51 |
| ▸ | SCN9A | Q15858 | 7/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12450037 | 0.91 | SCN9A (0.45) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL13843554 | 0.90 | KCNH2 (0.54) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL12154531 | 0.90 | SCN9A (0.44) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL10082380 | 0.89 | KCNH2 (0.52) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL5048195 | 0.89 | KCNH2 (0.52) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL13563554 | 0.88 | KCNH2 (0.51) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL13563536 | 0.87 | KCNH2 (0.50) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL12053967 | 0.84 | KCNH2 (0.63) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL14081198 | 0.84 | KCNH2 (0.54) | KCNH2SCN9ANR1I2CYP3A4SCN5A | |
| SCHEMBL850768 | 0.84 | KCNH2 (0.52) | KCNH2SCN9ANR1I2CYP3A4SCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008112848-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008112473-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-09-18 | — | — | WO | disclosed |